Alkem Laboratories Ltd Financials
Company Logo

Alkem Laboratories Ltd Financial Statement

Alkem Laboratories Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Mar 2025
Revenue2207.59
Operating Expense1748.15
Net Profit276.94
Net Profit Margin12.54
Earning Per Share18.89
EBIDTA422.24
Effective Tax Rate8.00

Alkem Laboratories Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual9,747.72
Operating Expenses Annual7,782.59
Operating Profit Annual2,207.29
Interest Annual81.91
Depreciation217.71
Net Profit Annual1,747.15
Tax Annual133.88

Alkem Laboratories Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning5.01
Cash Flow from Operations1,686.56
Cash Flow from Investing-865.60
Cash Flow from Financing-959.04
Cash Flow at the End-133.07

Alkem Laboratories Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)22.64
PBIT Margin (%)20.14
PBT Margin (%)19.89
Net PROFIT Margin (%)17.92
Return On Networth / Equity (%)17.56
Return On Networth /Employed (%)17.28
Return On Assets (%)15.41
Total Debt / Equity (X)0.11
Asset Turnover Ratio (%)0.86

Alkem Laboratories Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual1,823.09
Total Current Assets Annual8,040.08
Non Current Assets Annual5,997.72
Total Shareholders Funds Annual10,554.61
Total Assets Annual14,037.80

Alkem Laboratories Ltd Earning Calls

EPS (INR)

Expected

25.58

Reported

25.57

Surprise

-0.04%

Dec 2024

EPS beaten by -0.04%

Sep 2024

EPS beaten by -0.02%

Jun 2024

EPS beaten by 0.00%

FAQS on Alkem Laboratories Ltd Financials

As of May 30, 2025, Alkem Laboratories Ltd has a market capitalization of 59,067.50 Cr. Value Research classifies it as a Large-Cap company.

Yes, Alkem Laboratories Ltd is with a debt-to-equity ratio of 0.10.

In FY 2024 , Alkem Laboratories Ltd recorded a total revenue of approximately 7,963.85 Cr marking a significant milestone in the company's financial performance.

Alkem Laboratories Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.2% and -0.1% annually, respectively..

Alkem Laboratories Ltd's current PE ratio is 33.81.

Alkem Laboratories Ltd's ROCE averaged 15.2% from the FY ending March 2022 to 2024, with a median of 16.0%. It peaked at 16.2% in March 2022, reflecting strong capital efficiency over the period..

Alkem Laboratories Ltd's latest EBIT is Rs. 1,860.84 Cr, surpassing the average EBIT of Rs. 1,688.50 Cr over the 5 years..

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions